NCT03545490

Brief Summary

The target population in the present study is Chinese patients with oral and oropharyngeal cancer who plan to receive radio(chemo)therapy after surgical resection in the outpatient department. Investigators hypothesize that early enteral nutrition intervention, which is initiated 2 weeks before the start of postoperative radio(chemo)therapy treatment and added on demand during radiotherapy, will improve patients' nutritional status, tolerability to the radio(chemo)therapy, quality of life, and other clinical outcomes compared to commencement of oral nutritional supplements during the course of irradiation treatment. There are two cohorts in this trial, cohort 1 included patients with oral nutritional supplements and cohort 2 included patients with tube feeding (nasogastric tube or percutaneous endoscopic gastrostomy).

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
110

participants targeted

Target at P50-P75 for phase_2

Timeline
Completed

Started Jun 2017

Longer than P75 for phase_2

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

June 1, 2017

Completed
10 months until next milestone

First Submitted

Initial submission to the registry

March 21, 2018

Completed
3 months until next milestone

First Posted

Study publicly available on registry

June 4, 2018

Completed
2.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 31, 2020

Completed
1.7 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

December 18, 2023

Status Verified

August 1, 2020

Enrollment Period

3.4 years

First QC Date

March 21, 2018

Last Update Submit

December 12, 2023

Conditions

Outcome Measures

Primary Outcomes (1)

  • Body weight

    changes of body weight from baseline to Final Visit/Exit.

    10 weeks

Secondary Outcomes (20)

  • Body weight

    2weeks,5 weeks, 8 weeks

  • Body Mass Index

    10 weeks

  • Calf circumference by measure

    5weeks, 10 weeks

  • Lean mass measured by Bioelectrical impedance analysis (BIA)

    5weeks 10 weeks

  • Fat mass measured by Bioelectrical impedance analysis (BIA)

    5weeks 10 weeks

  • +15 more secondary outcomes

Study Arms (4)

Cohort 1-intervention

EXPERIMENTAL

Oral supplements are given through oral route 2 weeks before radiotherapy.

Dietary Supplement: Early nutritional intervention

Cohort 1-Control

ACTIVE COMPARATOR

Oral supplements are given through oral route on demand during radiotherapy.

Dietary Supplement: Early nutritional intervention

Cohort 2- Intervention

EXPERIMENTAL

Oral supplements are given by tube feeding 2 weeks before radiotherapy.

Dietary Supplement: Early nutritional intervention

Cohort 2- Control

ACTIVE COMPARATOR

Oral supplements are given by tube feeding on demand during radiotherapy.

Dietary Supplement: Early nutritional intervention

Interventions

Early nutritional intervention (Ensure) was given two weeks before radiotherapy. Ensure 3 times per day, Mixing 55.8 g or 6 spoons of Ensure with 190 mL of warm water.

Cohort 1-ControlCohort 1-interventionCohort 2- ControlCohort 2- Intervention

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Subject is male or female, between 18 and 70 years old;
  • Subject has clinical or radiological diagnosis of oral cancer (stage III and stage IV), had surgical resection 3 or 4 weeks prior to radio (chemo)therapy, and plans to receive radio (chemo)therapy treatment;
  • Subject has Karnofsky Performance Score (KPS) ≥ 60 and an expected life expectancy ≥ 6 months;
  • Subject is willing to comply with the study protocol, able and willing to consume study product according to the protocol;
  • Subject has voluntarily signed and dated the informed consent form (ICF), approved by an Institutional Review Board (IRB) / Independent Ethics Committee (IEC) prior to any participation in the study

You may not qualify if:

  • Except for oral cancer and oropharyngeal cancer, subject has malignant tumors or serious infectious diseases, such as tuberculosis activity, respiratory system, cardiovascular system, urinary system diseases, systemic edema and ascites caused by diseases, etc., cannot participant in study in the opinion of study physician.
  • Subject has dysfunction of liver, kidney or gallbladder, cannot participant in study in the opinion of study physician.
  • Subject has gastrointestinal diseases to cannot tolerate enteral nutrition (such as intestinal bleeding, intestinal obstruction, severe digestive malabsorption, severe nausea and vomiting and diarrhea) that preclude his or her participation in the opinion of study physician;
  • Subject has diabetes
  • Subject has known history of allergy or intolerance to any ingredient in the investigational product;
  • Female subjects are pregnant or plan to get pregnant within a year or are postpartum and non-lactating;
  • Subject has mental illness, cannot understand ICF, unwilling to provide informed consent.
  • Subject has amputation or implanted electronic devices or metal, it may be inappropriate to use BIA to measure body composition
  • Subject is currently or has participated in any clinical trial 2 months prior to enrollment.
  • Subject plans to take nutritional supplements and/or traditional Chinese medicine regularly during study in the opinion of study physician. Multi-vitamin and multi-mineral supplements are exception.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shanghai ninth people's hospital

Shanghai, Shanghai Municipality, 200011, China

Location

Related Publications (1)

  • Jiang W, Zhang H, Dou S, He Y, Zhu G, Li R. Effectiveness of Early Oral Nutritional Supplementation in Preventing Weight Loss in Head and Neck Cancer Patients Undergoing Postoperative Radiotherapy or Chemoradiotherapy: A Prospective Randomized Controlled Trial. J Am Nutr Assoc. 2025 Aug;44(6):498-507. doi: 10.1080/27697061.2025.2458277. Epub 2025 Feb 4.

MeSH Terms

Conditions

Malnutrition

Condition Hierarchy (Ancestors)

Nutrition DisordersNutritional and Metabolic Diseases

Study Officials

  • Guopei Zhu

    Shanghai 9th people hospital

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
phase 2
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Model Details: Cohort 1: nutritional supplements are given through oral route Cohort 2: nutritional supplements are given by tube feeding
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Director

Study Record Dates

First Submitted

March 21, 2018

First Posted

June 4, 2018

Study Start

June 1, 2017

Primary Completion

October 31, 2020

Study Completion

June 30, 2022

Last Updated

December 18, 2023

Record last verified: 2020-08

Locations